Trexquant Investment LP Takes Position in Phibro Animal Health Corporation $PAHC

Trexquant Investment LP bought a new stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 18,032 shares of the company's stock, valued at approximately $385,000.

Several other large investors have also recently made changes to their positions in the business. Brant Point Investment Management LLC purchased a new position in shares of Phibro Animal Health during the first quarter valued at approximately $2,216,000. Virtus Advisers LLC purchased a new position in shares of Phibro Animal Health during the first quarter valued at approximately $1,166,000. Quantbot Technologies LP lifted its holdings in shares of Phibro Animal Health by 53.8% during the first quarter. Quantbot Technologies LP now owns 7,870 shares of the company's stock valued at $168,000 after purchasing an additional 2,754 shares during the last quarter. Algert Global LLC lifted its holdings in shares of Phibro Animal Health by 1.4% during the first quarter. Algert Global LLC now owns 97,612 shares of the company's stock valued at $2,085,000 after purchasing an additional 1,340 shares during the last quarter. Finally, Russell Investments Group Ltd. lifted its holdings in shares of Phibro Animal Health by 711.1% during the first quarter. Russell Investments Group Ltd. now owns 122,600 shares of the company's stock valued at $2,619,000 after purchasing an additional 107,485 shares during the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Trading Down 0.1%

Shares of PAHC stock opened at $39.43 on Tuesday. Phibro Animal Health Corporation has a 1 year low of $16.16 and a 1 year high of $39.90. The firm has a fifty day moving average price of $30.93 and a 200-day moving average price of $25.03. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.76 and a quick ratio of 1.25. The company has a market cap of $1.60 billion, a price-to-earnings ratio of 33.42, a PEG ratio of 1.18 and a beta of 0.88.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.52 by $0.05. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. The firm had revenue of $378.70 million during the quarter, compared to the consensus estimate of $362.24 million. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. As a group, equities analysts predict that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.2%. Phibro Animal Health's payout ratio is presently 40.68%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. Bank of America lifted their target price on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an "underperform" rating in a report on Friday, August 29th. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a report on Monday, June 16th. Zacks Research lowered shares of Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a report on Thursday, August 28th. Morgan Stanley set a $34.00 price objective on shares of Phibro Animal Health in a report on Thursday, August 28th. Finally, JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $25.00 to $35.00 in a report on Monday, July 7th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Reduce" and an average price target of $28.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.